Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 3/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21939513 | 0.90 | ALDH1A1 (0.49) | CA2CA12CA1CA7CA9 | |
| SCHEMBL21939119 | 0.87 | TSHR (0.53) | CA2CA12CA1CA7CA9 | |
| SCHEMBL12134827 | 0.83 | POLB (0.56) | CA2CA12CA1CA7CA9 | |
| SCHEMBL12248741 | 0.82 | CYP3A4 (0.60) | CA9ALDH1A1SMN1; SMN2CNR2ACHE | |
| SCHEMBL7718116 | 0.82 | CA12 (0.59) | CA2CA12CA1CA7CA9 | |
| SCHEMBL9515990 | 0.82 | CA1 (0.69) | CA2CA12CA1CA7CA9 | |
| SCHEMBL466144 | 0.82 | CYP3A4 (0.60) | CA2CA12CA1CA7CA9 | |
| SCHEMBL16503418 | 0.82 | PTGS1 (0.47) | CA2CA12CA1CA7CA9 | |
| SCHEMBL24890451 | 0.80 | ACHE (0.48) | CA2CA12CA1CA7CA9 | |
| SCHEMBL1004368 | 0.80 | ACHE (0.48) | ALDH1A1SMN1; SMN2CNR2ACHEPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| EP-4477693-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2024-12-18 | — | — | EP | claimed |
| WO-2023195794-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | 한국화학연구원 | 2023-10-12 | — | — | WO | claimed |
| WO-2023121411-A1 | ECO-FRIENDLY METHOD FOR DECOLORIZATION AND DEPOLYMERIZATION OF COLORED POLYMER CONTAINING ESTER FUNCTIONAL GROUP | 한국화학연구원 | 2023-06-29 | — | — | WO | claimed |
| CN-105732291-B | A kind of preparation method of perhydro fluorenes or perhydro fluorenes alkyl substituents | 天津大学 | 2018-01-30 | — | — | CN | claimed |
| CN-105732291-A | Preparation method of perhydrofluorene or perhydrofluorene alkyl substitute | 天津大学 | 2016-07-06 | — | — | CN | claimed |
| EP-4737508-A1 | CHEMICAL RECYCLING METHOD FOR MIXED WASTE POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | disclosed |
| WO-2025029018-A1 | CHEMICAL RECYCLING METHOD FOR MIXED WASTE POLYMERS | 한국화학연구원 | 2025-02-06 | — | — | WO | disclosed |
| EP-4477693-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2024-12-18 | — | — | EP | disclosed |
| CN-114605404-B | Novel thiazole-containing compound, intermediate and application thereof | 合肥美诺医药有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-11839613-B2 | Pyrimidine derivatives as PGE2 receptor modulators | IDORSIA PHARMACEUTICALS LTD (CH) | 2023-12-12 | — | — | US | disclosed |
| US-11839613-B2 | Pyrimidine derivatives as PGE2 receptor modulators | IDORSIA PHARMACEUTICALS LTD (CH) | 2023-12-12 | — | — | US | disclosed |
| US-20040043995-A1 | Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them | BIGNON ERIC (FR) | 2004-03-04 | — | — | US | disclosed |
| US-5534530-A | CHOLECYSTOKININ AGONIST OR ANTAGONIST | ELF SANOFI (FR) | 1996-07-09 | — | — | US | disclosed |
| EP-0344414-B1 | 5-Substitued imidazo[4,5-c]pyridines | SEARLE & CO (US) | 1994-10-12 | — | — | EP | disclosed |
| US-5302601-A | Useful in the treatment of diseases mediated by platelet activating factor | G. D. SEARLE & CO. (US) | 1994-04-12 | — | — | US | disclosed |
| US-5227384-A | Platelet activating factor antagonist | G. D. SEARLE & CO. (US) | 1993-07-13 | — | — | US | disclosed |
| US-5019581-A | 5-substituted (4,5-c) imidazopyridine compounds which have useful platelet activating factor antagonistic activity | G. D. SEARLE & CO. (US) | 1991-05-28 | — | — | US | disclosed |
| EP-0344414-A1 | 5-Substitued imidazo[4,5-c]pyridines | G.D. Searle & Co. (US) | 1989-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040043995-A1 | Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them | CCKAR, CCKBR, NPY1R | CA2 2036/4885CA12 4305/4885CA1 2907/4885 |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | FGB, NR4A1, CYP2E1 | CA2 3093/4885CA12 1007/4885CA1 2951/4885 |
| US-11839613-B2 | Pyrimidine derivatives as PGE2 receptor modulators | PTGER1, PTGER4, PTGER2 | CA2 3989/4885CA12 4815/4885CA1 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.